tiprankstipranks
Genetic Technologies Faces NASDAQ Compliance Challenge
Company Announcements

Genetic Technologies Faces NASDAQ Compliance Challenge

Genetic Technologies (GENE) has released an update.

Pick the best stocks and maximize your portfolio:

Genetic Technologies Limited has been notified by NASDAQ that its stockholders’ equity is below the required minimum for continued listing, prompting the company to submit a compliance plan by December 6, 2024. Though the notification has no immediate effect on its NASDAQ listing, the company must present an acceptable strategy to regain compliance. Investors will be watching closely as Genetic Technologies navigates this challenge while continuing to trade under the symbol ‘GENE.’

For further insights into GENE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGenetic Technologies Faces Nasdaq Delisting Amid Financial Struggles
TipRanks Auto-Generated NewsdeskGenetic Technologies Embraces Corporate Governance Standards
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App